SSTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SoundThinking Inc (SSTI) is not a strong buy for a beginner, long-term investor at this time. While the company has shown revenue growth and a strategic outlook, the recent financial performance, technical indicators, and analyst sentiment suggest caution. The lack of strong trading signals and the presence of near-term uncertainties make it prudent to hold off on investing until clearer growth trends or catalysts emerge.
The technical indicators for SSTI are mixed to bearish. The MACD is below zero and negatively contracting, indicating weak momentum. RSI is neutral at 55.257, suggesting no clear overbought or oversold conditions. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot level of 7.125, with resistance at 7.905 and support at 6.346. Overall, the technical outlook does not support a strong buy signal.
The company reported record revenue of $104.1 million for Q4 2025, with a 5.89% YoY revenue increase. Gross margin improved slightly to 51.39%. Analysts still see the company as an inexpensive market leader with potential near-term catalysts.
The company lowered its 2026 revenue guidance due to delays in two large deals and international deployments, creating uncertainty around growth durability. Analysts have downgraded the stock, citing near-term challenges and reduced confidence in revenue and margin recovery. The non-GAAP EPS for Q4 2025 was -$0.20, with a net income loss of $2.8 million, reflecting continued financial struggles.
In Q4 2025, revenue increased by 5.89% YoY to $24.79 million, but net income dropped by 32.04% YoY to -$2.77 million. EPS also declined by 31.25% YoY to -$0.22. While gross margin improved slightly to 51.39%, the overall financial performance shows a mixed picture with ongoing profitability challenges.
Analysts have mixed to negative sentiment. Lake Street lowered its price target to $12 from $14 but maintained a Buy rating, citing near-term catalysts despite investor frustration. Cantor Fitzgerald downgraded the stock to Neutral from Overweight, reducing the price target to $10 from $16, citing go-to-market challenges, delayed deployments, and uncertainty around growth durability.
